DENDRITIC CELLS OFFER NEW THERAPEUTIC TARGET FOR DRUGS TO TREAT MS AND OTHER AUTOIMMUNE DISEASE (Ultashape)
DENDRITIC CELLS OFFER NEW THERAPEUTIC TARGET FOR DRUGS TO TREAT MS AND OTHER AUTOIMMUNE DISEASE
Scientists at the Johns Hopkins Kimmel Cancer Center have found that a gene pathway linked to a deadly form of leukemia may provide a new way to treat autoimmune diseases, including multiple sclerosis. Their tests in cell cultures and mice suggest that blocking the pathway by interfering with a blood cell growth gene, known as FLT3, targets an immune system cell often ignored in favor of T cell targets in standard therapies.
FDA Approval Of Dangerous Implants During Lame Duck Session Follows Pattern Of Favoring Money And Politics Over Science
The Food and Drug Administration (FDA) issued final approval to manufacturers Allergen Corporation (formerly Inamed) and Mentor Corp. for general marketing of silicone gel-filled breast implants to women of all ages for reconstruction purposes and women 22 and older for augmentation purposes. "Women should be outraged by this reckless decision. [click link for full article]
posted by Mr.Health at
2:17 AM
